Alantra advised Sangamo Therapeutics on the public tender offer followed by a squeeze-out on TxCell
SECTORHealthcare
ServiceM&A; Equity Capital Markets
Related Transactions
-
May 2025Sell-side advisoryMay 2025SECTOR Consumer Goods & Retail; HealthcareService M&A
-
Apr 2025Sell-side advisoryApr 2025SECTOR HealthcareService M&A
-
Apr 2025Sell-side advisoryApr 2025SECTOR HealthcareService M&A
-
Apr 2025Accelerated BookbuildingValue c. €42.4mnApr 2025SECTOR HealthcareService Equity Capital MarketsValue c. €42.4mn